½ÃÀ庸°í¼­
»óǰÄÚµå
1572438

Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ±âȸ, ¼ºÀå µ¿ÀÎ, »ê¾÷ µ¿Ç⠺м® ¹× ¿¹Ãø(2024-2032³â)

Orthopedic Software Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Global Market Insights Inc. | ÆäÀÌÁö Á¤º¸: ¿µ¹® 130 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 3¾ï 7,840¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.9% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå È®´ëÀÇ ÁÖ¿ä ¿äÀÎÀº Á¤Çü¿Ü°úÀû ¼Õ»ó ¹ß»ý·ü Áõ°¡¿Í ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ÀÔ´Ï´Ù.

Á¤Çü¿Ü°úÀû ¼Õ»óÀÌ ±ÞÁõÇϸ鼭 °í±Þ Áø´Ü, Ä¡·á ¹× °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±× ¿äÀÎÀ¸·Î´Â ½Åü Ȱµ¿ ¹× ½ºÆ÷Ã÷ Âü¿© Áõ°¡·Î ÀÎÇÑ Á¤Çü¿Ü°úÀû ¼Õ»ó Áõ°¡, ³ëÈ­·Î ÀÎÇÑ ±Ù°ñ°Ý°è Áúȯ¿¡ Á÷¸éÇÑ °í·ÉÈ­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ Áúº´ÅëÁ¦¿¹¹æ¼¾ÅÍ(CDC)´Â ¹Ì±¹¿¡¼­ ¿¬°£ ¾à 770¸¸ ¸íÀÌ Á¤Çü¿Ü°úÀû ¼Õ»óÀ¸·Î ÀÀ±Þ Ä¡·á¸¦ ¹Þ°í ÀÖ´Ù°í ÁöÀûÇϸç, Á¤Çü¿Ü°ú Àü¹® ¼ÒÇÁÆ®¿þ¾î¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¸¦ °­Á¶Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾îÀÇ ¹üÀ§¿Í ±â´ÉÀ» È®ÀåÇϰí, ȯÀÚ Ä¡·á °­È­, ¼ö¼úÀÇ Á¤±³È­, ÀÇÇÐ ±³À°ÀÇ °íµµÈ­¸¦ ÅëÇØ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î¿¡ AI¿Í ¸Ó½Å·¯´×ÀÌ Á¢¸ñµÇ¸é¼­ Áø´Ü°ú Ä¡·á°¡ ¿ÏÀüÈ÷ ´Þ¶óÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Áø´Ü À̹ÌÁö ºÐ¼®, ¼ö¼ú °á°ú ¿¹Ãø, ¸ÂÃãÇü Ä¡·á °èȹÀ» ¿ëÀÌÇÏ°Ô ÇÏ¿© ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü°ú ´õ ³ªÀº Á¤º¸¿¡ ÀÔ°¢ÇÑ °áÁ¤À» ³»¸®°í ȯÀÚ Ä¡·á¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

Á¦Ç° À¯Çüº°·Î Á¤Çü¿Ü°ú EHR, Á¤Çü¿Ü°ú PACS, Á¤Çü¿Ü°ú RCM, Á¤Çü¿Ü°ú Áø·á °ü¸®, µðÁöÅÐ ÅÛÇø´/¼ö¼ú Àü °èȹ ¼ÒÇÁÆ®¿þ¾î·Î ±¸ºÐµË´Ï´Ù. Á¤Çü¿Ü°ú EHR ºÎ¹®Àº 2023³â 1¾ï 3,080¸¸ ´Þ·¯·Î Æò°¡µÇ¾î ½ÃÀåÀ» Áö¹èÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº º´·Â, ¿µ»ó °á°ú, Ä¡·á °èȹÀ» Æ÷ÇÔÇÑ È¯ÀÚ ±â·Ï °ü¸®¸¦ Áß¾Ó ÁýÁßÈ­Çϱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áß¾Ó ÁýÁßÈ­´Â ȯÀÚ µ¥ÀÌÅÍ Ã³¸®ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó ¹®¼­È­, ¿¹¾à ¿¹¾à, û±¸¼­ ÀÛ¼º µîÀÇ °ü¸® ¾÷¹«¸¦ °£¼ÒÈ­ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ È¿À²¼ºÀº ¹æ´ëÇÑ È¯ÀÚ µ¥ÀÌÅÍ °ü¸®¿Í Á¤È®ÇÑ ¹®¼­È­°¡ ¾çÁúÀÇ ÀÇ·á ¼­ºñ½º¿¡ ÇʼöÀûÀΠȰ±âÂù Á¤Çü¿Ü°ú Áø·á¿¡ ÀÖ¾î °¡Àå Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù.

Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î ½ÃÀåÀº º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ »ç¿ëÀÚ µî ÃÖÁ¾ ¿ëµµº°·Î ¼¼ºÐÈ­µÇ¾î ÀÖ½À´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®Àº ºÐ¼® ±â°£ µ¿¾È 7.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´ÐÀº ȯÀÚ ¼ö°¡ ¸¹°í ´Ù¾çÇÑ Á¤Çü¿Ü°ú ¼­ºñ½º¸¦ Á¦°øÇϱ⠶§¹®¿¡ Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾îÀÇ ÁÖ¿ä ¼ö¿äóÀÔ´Ï´Ù. ȯÀÚ µ¥ÀÌÅÍ °ü¸®, ¼ö¼ú °èȹ ¹× Ä¡·á °úÁ¤ÀÇ º¹À⼺, ÃÊÁøºÎÅÍ ÈÄ¼Ó Á¶Ä¡±îÁö ÅëÇÕµÈ ¼ÒÇÁÆ®¿þ¾î°¡ ÇÊ¿äÇϱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô½À´Ï´Ù.

ºÏ¹Ì Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 1¾ï 4,970¸¸ ´Þ·¯·Î 2032³â±îÁö 6.5%ÀÇ ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è ÀÇ·áºñ ÁöÃâÀ» ÁÖµµÇÏ´Â ¹Ì±¹ÀÌ Ã·´Ü Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î äÅÃÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ºÏ¹ÌÀÇ ÅºÅºÇÑ ±â¼ú ÀÎÇÁ¶ó¿Í ÷´Ü ±â¼úÀ» ÇコÄɾ ÅëÇÕÇÏ·Á´Â ³ë·ÂÀÌ Ã·´Ü Á¤Çü¿Ü°ú ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ ºü¸¥ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

  • »ýÅÂ°è ºÐ¼®
  • ¾÷°è¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾÷°èÀÇ ÀáÀçÀû ¸®½ºÅ©£¦°úÁ¦
  • ¼ºÀå °¡´É¼º ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ½ºÅ¸Æ®¾÷ ½Ã³ª¸®¿À
  • ±â¼úÀû Àü¸Á
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • ÇâÈÄ ½ÃÀå µ¿Çâ
  • °¸ ºÐ¼®

Á¦4Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ±â¾÷ ¸ÅÆ®¸¯½º ºÐ¼®
  • ÁÖ¿ä ½ÃÀå ±â¾÷ - °æÀï ºÐ¼®
  • °æÀï Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • Àü·« ´ë½Ãº¸µå

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦Ç° À¯Çüº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Á¤Çü¿Ü°ú EHR
  • Á¤Çü¿Ü°ú PACS
  • Á¤Çü¿Ü°ú RCM
  • Á¤Çü¿Ü°ú Áø·á °ü¸®
  • µðÁöÅÐ ÅÛÇø´/¼ö¼úÀü °èȹ ¼ÒÇÁÆ®¿þ¾î

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Á¦°ø ¸ðµåº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Ŭ¶ó¿ìµå/À¥ ±â¹Ý
  • ¿ÂÇÁ·¹¹Ì½º

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • Á¤Çü¿Ü°ú ¼ö¼ú
  • °ñÀý °ü¸®
  • °üÀý ġȯ¼ú
  • ±âŸ ¿ëµµ

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ÃÖÁ¾ ¿ëµµº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • º´¿ø ¹× Áø·á¼Ò
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021³â-2032³â

  • ÁÖ¿ä µ¿Çâ
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ³×´ú¶õµå
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦10Àå ±â¾÷ °³¿ä

  • Brainlab AG
  • Carestream Health
  • DePuy Synthes
  • Esaote
  • GE Healthcare
  • Intellijoint Surgical
  • Materialise NV
  • McKesson Corporation
  • Medstrat, Inc.
  • Merge Healthcare(IBM)
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Stryker Corporation
  • Surgimap
  • Zimmer Biomet
LSH 24.10.28

The Global Orthopedic Software Market was valued at USD 378.4 million and is projected to grow at a CAGR of 6.9% from 2024 to 2032. The market's expansion is primarily fueled by the rising incidence of orthopedic injuries and an increasing preference for minimally invasive surgeries.

The surge in orthopedic injuries is driving market growth, leading to heightened demand for sophisticated diagnostic, treatment, and management solutions. Contributing factors include increased physical activity and sports participation, resulting in more orthopedic injuries, and an aging population facing age-related musculoskeletal issues. Furthermore, the Centers for Disease Control and Prevention (CDC) notes that around 7.7 million individuals in the U.S. seek emergency care annually for orthopedic injuries, highlighting the growing demand for specialized orthopedic software.

Technological advancements are broadening the scope and capabilities of orthopedic software, propelling market growth by enhancing patient care, refining surgical procedures, and elevating medical education. The incorporation of AI and machine learning in orthopedic software is transforming diagnostics and treatment. These innovations facilitate diagnostic image analysis, surgical outcome predictions, and tailored treatment plans, resulting in swift, accurate diagnoses and better-informed decisions, thereby elevating patient care.

The overall orthopedic software industry is classified based on product type, delivery mode, application, end-use, and region.

The market is segmented by product type into orthopedic EHR, orthopedic PACS, orthopedic RCM, orthopedic practice management, and digital templating/preoperative planning software. Dominating the market, the orthopedic EHR segment was valued at USD 130.8 million in 2023, as these systems centralize patient record management, encompassing history, imaging results, and treatment plans. This centralization not only boosts efficiency and accuracy in handling patient data but also streamlines administrative tasks like documentation, appointment scheduling, and billing. Such efficiency is paramount in bustling orthopedic practices, where managing extensive patient data and ensuring precise documentation is vital for quality care.

Segmented by end-use, the orthopedic software market includes hospitals and clinics, ambulatory surgical centers, and other users. The hospitals and clinics segment is projected to grow at a CAGR of 7.6% during the analysis period. Given their high patient load and the diverse range of orthopedic services they offer, hospitals and clinics are major consumers of orthopedic software. The complexity of managing patient data, surgical planning, and treatment processes, coupled with the need for integrated software from initial consultation to follow-up, underscores their significant demand for such solutions.

North American Orthopedic Software market was valued at USD 149.7 million, with a projected growth rate of 6.5% through 2032. The U.S., leading in global healthcare expenditure, drives the adoption of advanced orthopedic software. This is further bolstered by North America's robust technological infrastructure and commitment to integrating state-of-the-art technologies into healthcare, facilitating the swift uptake of advanced orthopedic software solutions.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of orthopedic disorders
      • 3.2.1.2 Technological advancements in orthopedic software
      • 3.2.1.3 Growing demand for minimally invasive surgeries
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Potential risks of software malfunction
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Start-up scenario
  • 3.6 Technological landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Orthopedic EHR
  • 5.3 Orthopedic PACS
  • 5.4 Orthopedic RCM
  • 5.5 Orthopedic practice management
  • 5.6 Digital templating/ preoperative planning software

Chapter 6 Market Estimates and Forecast, By Delivery Mode, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cloud/web-based
  • 6.3 On-premises

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Orthopedic surgeries
  • 7.3 Fracture management
  • 7.4 Joint replacements
  • 7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Ambulatory surgical centers
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Brainlab AG
  • 10.2 Carestream Health
  • 10.3 DePuy Synthes
  • 10.4 Esaote
  • 10.5 GE Healthcare
  • 10.6 Intellijoint Surgical
  • 10.7 Materialise NV
  • 10.8 McKesson Corporation
  • 10.9 Medstrat, Inc.
  • 10.10 Merge Healthcare (IBM)
  • 10.11 Koninklijke Philips N.V.
  • 10.12 Siemens Healthineers
  • 10.13 Stryker Corporation
  • 10.14 Surgimap
  • 10.15 Zimmer Biomet
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦